Passa al contenuto
Merck
Tutte le immagini(1)

Documenti fondamentali

Visualizza tutta la documentazione

I0775000

Isosorbide dinitrate

European Pharmacopoeia (EP) Reference Standard

Sinonimo/i:

ISDN

Autenticatiper visualizzare i prezzi riservati alla tua organizzazione & contrattuali
Tutte le immagini(1)

About This Item

Formula empirica (notazione di Hill):
C6H8N2O8
Numero CAS:
87-33-2
Peso molecolare:
236.14
Numero MDL:
MFCD00868238
Codice UNSPSC:
41116107
ID PubChem:
329815326
NACRES:
NA.24

Grado

pharmaceutical primary standard

Famiglia di API

isosorbide

Produttore/marchio commerciale

EDQM

applicazioni

pharmaceutical (small molecule)

Formato

neat

Stringa SMILE

[H][C@@]1([C@@]([H])(O[N+]([O-])=O)CO2)[C@@]2([H])[C@]([H])(O[N+]([O-])=O)CO1

InChI

1S/C6H8N2O8/c9-7(10)15-3-1-13-6-4(16-8(11)12)2-14-5(3)6/h3-6H,1-2H2
MOYKHGMNXAOIAT-UHFFFAOYSA-N

Cerchi prodotti simili? Visita Guida al confronto tra prodotti

Categorie correlate

Descrizione generale

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

Applicazioni

Isosorbide dinitrate EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

Confezionamento

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

Altre note

Sales restrictions may apply.

Prodotti correlati

N° Catalogo
Descrizione
Determinazione del prezzo

1352008

Isosorbide, United States Pharmacopeia (USP) Reference Standard

1353000

Diluted isosorbide dinitrate (25% mixture with lactose), United States Pharmacopeia (USP) Reference Standard

I0775020

Isosorbide 2-nitrate, European Pharmacopoeia (EP) Reference Standard

I0775010

Isosorbide mononitrate, European Pharmacopoeia (EP) Reference Standard

PHR1486

Isosorbide Solution, Pharmaceutical Secondary Standard; Certified Reference Material

1353102

Diluted Isosorbide Mononitrate, United States Pharmacopeia (USP) Reference Standard

1353113

Diluted Isosorbide Mononitrate Related Compound A, United States Pharmacopeia (USP) Reference Standard

Pittogrammi

FlameExclamation mark
GHS02,GHS07

Avvertenze

Warning

Indicazioni di pericolo

H207,H302

Classi di pericolo

Acute Tox. 4 Oral - Desen. Expl. 3

Codice della classe di stoccaggio

4.1B - Flammable solid hazardous materials

Classe di pericolosità dell'acqua (WGK)

WGK 3

Punto d’infiammabilità (°F)

Not applicable

Punto d’infiammabilità (°C)

Not applicable

Scegli una delle versioni più recenti:

Certificati d'analisi (COA)

Lot/Batch Number

Ci dispiace, ma al momento non ci sono COA disponibili online per questo prodotto.

Se ti serve aiuto, non esitare a contattarci Servizio Clienti

Possiedi già questo prodotto?

I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.

Visita l’Archivio dei documenti

Giuseppe Di Gioia et al.
European heart journal, 41(17), 1665-1672 (2019-08-17)
Fractional flow reserve (FFR) has never been investigated in patients with reduced ejection fraction and associated coronary artery disease (CAD). We evaluated the impact of FFR on the management strategies of these patients and related outcomes. From 2002 to 2010
Takashi Kubo et al.
Journal of cardiology, 68(5), 455-460 (2016-10-19)
Optical coherence tomography is becoming increasingly widespread as an adjunctive intravascular diagnostic technique in percutaneous coronary intervention (PCI), because of its ability to visualize coronary structures at high resolution. Several studies have reported that intravascular ultrasound (IVUS) guidance in PCI
Kentaro Kakuta et al.
Cardiovascular diabetology, 16(1), 131-131 (2017-10-14)
Both the progression of diabetic kidney disease and increased glycemic variability play important roles in the pathogenesis of coronary plaque formation via inflammatory pathways in patients with type 2 diabetes mellitus (T2DM). Therefore we evaluated the role of renal function
Soo-Jin Kang et al.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 89(7), E207-E216 (2016-08-28)
Although ischemia-guided revascularization improves clinical outcomes, morphological determinants of clinically relevant myocardial ischemia have not been studied. To identify intravascular ultrasound (IVUS)-derived anatomical parameters for predicting myocardial perfusion defect and its extent. A total of 103 patients (88 stable and
Ryo Kurokawa et al.
Medicine, 98(19), e15538-e15538 (2019-05-15)
To compare coronary artery luminal enhancement in coronary computed tomography angiography (CCTA) between ventral and dorsal region-of-interest (ROI) bolus tracking in the descending aorta.The records of 165 consecutive patients who underwent CCTA with non-helical acquisition from July 2017 to March
Visualizza tutti i documenti correlati

Il team dei nostri ricercatori vanta grande esperienza in tutte le aree della ricerca quali Life Science, scienza dei materiali, sintesi chimica, cromatografia, discipline analitiche, ecc..

Contatta l'Assistenza Tecnica.